SCHEMBL23536116

SCHEMBL23536116

COCCC1(C)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HPGD P15428 1/20 0.39
EPHX2 P34913 1/20 0.39
GPR119 Q8TDV5 7/20 0.38
NAMPT P43490 1/20 0.38
RECQL P46063 1/20 0.38
EPHX1 P07099 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15368820 0.86 USP2 (0.49) USP2SMN1; SMN2HPGDEPHX2NAMPT
SCHEMBL15076623 0.85 USP2 (0.45) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL4975667 0.84 USP2 (0.47) USP2SMN1; SMN2HPGDEPHX2RECQL
SCHEMBL24187925 0.84 USP2 (0.42) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL15076622 0.84 USP2 (0.44) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL21855832 0.84 USP2 (0.44) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL3156006 0.84 USP2 (0.44) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL345260 0.83 USP2 (0.46) USP2SMN1; SMN2HPGDEPHX2RECQL
SCHEMBL2799150 0.82 USP2 (0.43) USP2SMN1; SMN2HPGDEPHX2GPR119
SCHEMBL21644360 0.82 USP2 (0.43) USP2SMN1; SMN2HPGDEPHX2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076423-A1 TRPML MODULATORS Casma Therapeutics, Inc. (US) 2022-10-26 EP disclosed
WO-2021127337-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed
WO-2021127328-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed